Drug susceptibility patterns in 2000 patients de novo infected with drug resistant virus: implications for first-line antiretroviral therapy and PEP

Wensing, AMJ; Van de Vijver, DAMC; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; de Luca, A; Maljkovic, I; de Mendoza, C; Deroo, S; Derdelinckx, Inge; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, A; Horban, A; Korn, K; Kuecherer, C; Leitner, E; Loveday, C; Macrae, E; Nielsen, C; Ormaasen, V; Perrin, L; Paraskevis, D; Puchhammer, E; Roman, F; Ruiz, L; Salminen, M; Schmit, JCC; Schuurman, R; Soriano, V; Stanczak, G; Stanojevic, M; Vandamme, A-M; Van Laethem, Kristel; Violin, M; Wilbe, K; Yerly, S; Zazzi, M; Boucher, CAB

Drug susceptibility patterns in 2000 patients de novo infected with drug resistant virus: implications for first-line antiretroviral therapy and PEP

Author:

Wensing, AMJ

Van de Vijver, DAMC ; Angarano, G ; Asjo, B ; Balotta, C ; Boeri, E ; Camacho, R ; de Luca, A ; Maljkovic, I ; de Mendoza, C ; Deroo, S ; Derdelinckx, Inge ; Grossman, Z ; Hamouda, O ; Hatzakis, A ; Hoepelman, A ; Horban, A ; Korn, K ; Kuecherer, C ; Leitner, E ; Loveday, C ; Macrae, E ; Nielsen, C ; Ormaasen, V ; Perrin, L ; Paraskevis, D ; Puchhammer, E ; Roman, F ; Ruiz, L ; Salminen, M ; Schmit, JCC ; Schuurman, R ; Soriano, V ; Stanczak, G ; Stanojevic, M ; Vandamme, A-M ; Van Laethem, Kristel ; Violin, M ; Wilbe, K ; Yerly, S ; Zazzi, M ; Boucher, CAB